TERN position history
The shares of Terns Pharmaceuticals (TERN) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 642,000 shares, $26M, 0.12% of portfolio, New
- 2026 Q1: 7,000 shares, $369K, <0.01% of portfolio, Reduce −98.9%
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|